Characterisation of antibody responses induced by BCG and other TB vaccines to inform future vaccine design
Tuberculosis (TB) remains a pressing global health challenge. The focus of TB vaccine research traditionally centres on either enhancing BCG's efficacy or identifying a suit-able alternative. Within this context, antibody responses, a potentially relevant corre-late of protection, are inadequat...
第一著者: | Peralta Alvarez, MP |
---|---|
その他の著者: | Tanner, R |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2023
|
主題: |
類似資料
-
Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
著者:: Marco Polo Peralta Alvarez, 等
出版事項: (2024-05-01) -
Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations
著者:: Shalini Pooransingh, 等
出版事項: (2020-03-01) -
Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine
著者:: Nancy Gupta, 等
出版事項: (2018-10-01) -
Commentary: Bettering BCG: a tough task for a TB vaccine?
著者:: Brahm S. Srivastava, 等
出版事項: (2019-09-01) -
Mantoux test results and BCG vaccination status in TB-exposed children
著者:: Fadilah Harahap, 等
出版事項: (2015-03-01)